Mistras Group, Inc. — Form 10-Q Summary
Business context and reporting period. Mistras provides technology-enabled asset-protection, inspection, testing, and related products and systems to asset-intensive industries. This unaudited filing covers the quarter ended November 30, 2013 (fiscal Q2 2014) and the six months then ended; comparisons are with the corresponding 2012 periods. Dollar amounts below are in millions unless stated otherwise.
Financial performance and position
- Quarter: Revenue was $156.8, up 13.8% year over year. Services revenue was $108.9, International $43.2, and Products and Systems $8.6, before corporate eliminations.
- Gross profit was $48.0, with a 30.6% margin versus 30.4%. Operating income was $15.3, down about 3%, and operating margin declined to 9.7% from 11.4%. Net income attributable to Mistras was $9.3 versus $9.2; diluted EPS was $0.32, unchanged.
- Quarterly EBITDA was $22.0 versus $22.2; adjusted EBITDA, a non-GAAP measure, was $22.6 versus $23.9.
- Six months: Revenue was $292.6, up 16.5%; gross profit was $87.3, with a 29.8% margin versus 30.1%. Operating income was $24.8 versus $23.5, but operating margin fell to 8.5% from 9.3%. Net income attributable to Mistras was $14.9 versus $13.4, and diluted EPS was $0.51 versus $0.46. Adjusted EBITDA was $38.6 versus $39.3.
- Growth was mainly acquisition-driven: acquisitions contributed an estimated 9.4 percentage points of quarterly growth and 12.2 points for the six-month period; organic growth was 4.3% and 4.4%, respectively. International growth reflected the prior-year German acquisition. Products and Systems revenue and gross profit declined year to date, with lower sales and adverse mix weighing on margins.
- Cash flow: Six-month operating cash flow was $15.6 versus $27.4, largely reflecting a $12.5 use of cash from accounts receivable as sales grew. Investing used $20.2, including $8.2 of capital expenditures and an $11.0 acquisition deposit. Financing provided $13.1, principally from $22.0 of net revolver borrowings. Cash increased to $16.2 from $7.8 at May 31, 2013.
- Liquidity and debt: Current assets were $165.1 and current liabilities $74.1. Total debt was $78.7, up from $60.3 at May 31; revolving-facility borrowings were $61.6. The company reported $59.8 of available borrowing capacity, after $3.6 of letters of credit. Capital-lease obligations totaled $17.5. The $125.0 revolving facility matures December 20, 2016; the company said it was compliant with its financial covenants at quarter-end.
Material changes and management commentary
- Quarterly revenue growth was stronger in International and Services. International gross margin improved, while Services margin was below the prior-year quarter amid Canadian growth-related costs and medical-cost timing. Products and Systems margins remained pressured by sales mix.
- Operating expenses rose 25% in the quarter and 20% for the six-month period. Management cited acquisition impact, hiring and facility costs to support growth, and higher corporate insurance, recruiting, and performance-based compensation costs.
- Reported operating income benefited from a $0.8 reduction in estimated acquisition-related contingent consideration liabilities in the quarter and a $3.0 reduction for the six months. These noncash valuation benefits can make comparisons less representative of underlying operations.
- Management stated that cash, operating cash flow, and available borrowing sources were expected to fund operations for the foreseeable future. It described future cash uses as including acquisitions, international expansion, equipment, technology, leases, and debt repayments. Historical capital spending, including capital leases and excluding acquisitions, was approximately 3%–4% of revenue. The filing provides no quantified earnings or revenue guidance.
Risks, contingencies, and unusual items
- After November 30, the company completed an asset-protection business acquisition in Texas, funded by an initial $11.0 cash payment recorded as an acquisition-related deposit. Up to $4.0 of additional consideration may be payable if performance targets are met.
- Estimated potential contingent consideration for acquisitions ranged from zero to approximately $25.6 over the next five years; the recorded fair value at November 30 was approximately $12.0.
- A pipeline project owner alleged that radiographic images did not meet required quality standards and is claiming damages. No lawsuit had been filed; the company said it could not estimate the likely outcome or potential liability and had recorded no reserve. A separate environmental investigation was not expected by management to have a material effect.
- The business has foreign-currency exposure and does not currently hedge it with forward contracts. Top ten customers accounted for approximately 36% of quarterly revenue versus 32% a year earlier. The company also cautioned that global economic conditions remained fragile and that future funding may not be available on acceptable terms if needed.
Important facts for investors to verify
- Whether receivables convert to cash and operating cash flow recovers after the working-capital outflow.
- Whether operating margins improve as growth-related costs are absorbed, particularly in Services and Products and Systems.
- How much reported earnings depend on acquisition-related fair-value benefits, and whether adjusted EBITDA trends translate into cash generation.
- Debt, borrowing capacity, covenant headroom, and funding needs for acquisitions and capital spending.
- The outcome and potential exposure from the pipeline quality claim, and the final purchase accounting and performance-based consideration for acquisitions.